Simultaneous analysis of the local and systemic immune responses in mice to study the occupational asthma mechanisms induced by chromium and platinum

Toxicology

Volumn 277, Issue 1-3, 2010, Pages 29-37

  Ban, Masarin ^a   Langonné, Isabelle ^a   Goutet, Michèle ^a   Huguet, Nelly ^a   Pépin, Elsa ^a  

^a INSTITUT NATIONAL DE RECHERCHE ET DE SÉCURITÉ   (France)

Author keywords

Occupational asthma; Platinum and chromium exposure; Th2 dominated

Indexed keywords

CHROMIUM; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR ALPHA; INTERLEUKIN 5; PLATINUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EOSINOPHIL COUNT; FEMALE; HISTOLOGY; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; LUNG LAVAGE; LYMPH NODE CELL; MOUSE; NONHUMAN; OCCUPATIONAL ASTHMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; ASTHMA; BAGG ALBINO MOUSE; BIOSYNTHESIS; CHEMICALLY INDUCED; COMPARATIVE STUDY; DISEASE MODEL; ENDOTRACHEAL INTUBATION; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION; LYMPH NODE; METABOLISM; OCCUPATIONAL DISEASE; PATHOLOGY; TH1 CELL; TH2 CELL; TOXICITY;

ADMINISTRATION, INTRANASAL; ANIMALS; ASTHMA; CELLS, CULTURED; CHROMIUM; DISEASE MODELS, ANIMAL; FEMALE; INTERLEUKIN-13; INTERLEUKIN-4; INTUBATION, INTRATRACHEAL; LYMPH NODES; MICE; MICE, INBRED BALB C; OCCUPATIONAL DISEASES; PLATINUM; TH1 CELLS; TH2 CELLS;

MUS;

EID: 77957886099     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2010.08.010     Document Type: Article

References (37)

1. Akdis C.A., Akdis M. Mechanisms and treatment of allergic disease in the big picture of regulatory T cells. J. Allergy Clin. Immunol. 2009, 23:735-746.
2. Akkoc T., de Koning P.J., Ruckert B., Barlan I., Akdis M., Akdis C.A. Increased activation-induced cell death of high IFN-gamma-producing T(H)1 cells as a mechanism of T(H)2 predominance in atopic diseases. J. Allergy Clin. Immunol. 2008, 121:652-658.
3. Arts J.H.E., De Jong W.H., Van Triel J.J., Schijf A., De Klerk A., Van Loveren H., Kuper C.F. The respiratory local lymph node assay as a tool to study respiratory sensitizers. Toxicol. Sci. 2008, 106:423-434.
4. Ban M., Morel G., Langonné I., Huguet N., Pépin E., Binet S. TDI can induce respiratory allergy with Th-2 dominated response in mice. Toxicology 2006, 218:39-47.
5. Ban M., Langonné I., Huguet N., Pépin E., Morel G. Inhaled chemicals may enhance allergic airway inflammation in ovalbumin-sensitised mice. Toxicology 2006, 266:161-171.
6. Bauer X. Hypersensitivity pneumonitis (extrinsic allergic alveolis) induced by isocyanates. J. Allergy Clin. Immunol. 1995, 95:1004-1010.
7. Bolm-Audorff U., Bienfait H.G., Burkhard J., Bury A.H., Merget R., Preddel G., Schultze-Werninghaus G. Prevalence of respiratory allergy in platinum refinery. Int. Arch. Occup. Environ. Health 1992, 64:257-260.
8. Boggs P.B. Platinum allergy. Cutis 1985, 35:318-320.
9. Cristaudo A., Sera F., Severino V., De Rocco M., Di Lella E., Picardo M. Occupational hypersensitivity to metal salts, including platinum, in the secondary industry. Allergy 2005, 60:159-164.
10. Cromwell O., Pepys J., Parish W.H., Hughes E.G. Specific IgE antibodies to platinum salts in sensitized workers. Clin. Allergy 1979, 9:109-117.
11. Dayan A.D., Paine A.J. Mechanisms of chromium toxicity, carcinogenicity and allergenicity: review of the literature from 1985 to 2000. Hum. Exp. Toxicol. 2001, 20:439-451.
12. Dearman R.J., Basketter D.A., Kimber I. Selective induction of type 2 cytokines following topical exposure of mice to platinum salts. Food Chem. Toxicol. 1998, 36:199-207.
13. Ebino K., Lemus R., Korol M.H. The importance of diluent for airway transport of toluene diisocyanate following intranasal dosing of mice. Inhal. Toxicol. 1999, 11:171-185.
14. Forte G., Petrucci F., Bocca B. Metal allergens of growing significance: epidemiology, immunotoxicology, strategies for testing and prevention. Inflamm. Allergy: Drug Targets 2008, 7:1-18.
15. Foster P.S., Hogan S.P., Yang M., Mattes J., Young I.G., Mathaei K.I., Kumar R.K., Mahalingan S., Webb D.C. Interleukin-5 and eosinophils as therapeutic targets for asthma. Trends Mol. Med. 2002, 8:162-167.
16. Friedmann C., Moss C., Shuster S., Simpson J.M. Quantitative relationships between sensitising dose of DNCB and reactivity in normal subjects. Clin. Exp. Immunol. 1983, 53:709-711.
17. Fukuyama T., Ueda H., Hayashi K., Tajima Y., Shuto Y., Saito T.R., Harada T., Kosaka T. Use of long term dermal sensitization followed by intratracheal challenge method to identify low-dose chemical-induced respiratory allergic response in mice. Toxicol. Lett. 2008, 181:163-170.
18. Goutet M., Pépin E., Langonné I., Huguet N., Ban M. Identification of contact and respiratory sensitizers using flow cytometry. Toxicol Appl. Pharmacol. 2005, 205:259-270.
19. Grammer L.C., Ditto A.M., Tripathi A., Harris K.E. Prevalence and onset of rhinitis in subject with occupational asthma caused by trimellitic anhydride. J. Occup. Environ. Med. 2002, 44:117-1181.
20. Hannu T., Piipari R., Kasurinen H., Tuppurainen M., Tuomi T. Occupational asthma due to manual metal-arc welding of special stainless steels. Eur. Respir. J. 2005, 26:736-739.
21. Kang J.H., Kim B.S., Uhm T.G., Lee S.H., Lee G.R., Park C.S., Chung I.Y. γ-Secretase inhibitor reduces allergic pulmonary inflammation by modulating Th1 and Th2 responses. Am. J. Respir. Crit. Care Med. 2009, 179:875-882.
22. Kaplan M.H., Schindler U., Smiley S.T., Grushy M.J. Stat 6 is required for mediating response to IL-4 and for development of TH2 cells. Immunity 1996, 4:313-319.
23. Karol M.H., Tollerud D.J., Campbell T.P., Fabbri L., Maestrelli P., Saetta M., Mapp C.E. Predictive value of airways hyperresponsiveness and circulating IgE for identifying types of responses to toluene diisocyanate inhalation challenge. Am. J. Respir. Crit. Care Med. 1994, 149:611-615.
24. Létourneau S., Krieg C., Pantaleo G., Boyman O. IL-2 and CD25-dependent immunoregulatory mechanisms in the homeostasis of T-cell subsets. J. Allergy Clin. Immunol. 2009, 123:758-762.
25. Maestrelli P., Boschetto P., Fabbri L.D., Mapp C.E. Mechanisms of occupational asthma. J. Allergy Clin. Immunol. 2009, 123:531-542.
26. Minang J.T., Areström I., Troye-Blomberg M., Lundeberg L., Ahlborg N. Nickel, cobalt, chromium, palladium and gold induce a mixed Th1- and Th2-type cytokine response in vitro in subjects with contact allergy to the respective metals. Clin. Exp. Immunol. 2006, 146:417-426.
27. Mitchell L.M., Lauer F.M., Burchiel S.W., McDonald J.D. Mechanisms for how inhaled multiwalled carbon nanotubes suppress systemic immune function in mice. Nat. Nanotechnol. 2009, 4:451-456.
28. Mosmann T.R., Cherwinski H., Bond M.W., Giedlin M.A., Coffman R.L. Two types of murine helper T cell clone. I. Definition according to profile of lymphokine activities and secreted proteins. J. Immunol. 1986, 136:2348-2357.
29. Novey H.S., Habib M., Wells I.D. Asthma and IgE antibodies induced by chromium and nickel salts. J. Allergy Clin. Immunol. 1983, 72:407-412.
30. Oettgen H.C. Regulation of the isotype switch: new insights on cytokine signals and the functions of epsilon germline transcripts. Curr. Opin. Immunol. 2000, 12:618-623.
31. Park H.S., Yu H.J., Jung K.S. Occupational asthma caused by chromium. Clin. Exp. Allergy 1994, 24:676-681.
32. Pauluhn J. Brown Norway rat asthma model of diphenylmethane-4,4'-diisocyanate (MDI): analysis of the elicitation dose-response relationship. Toxicol Sci. 2008, 104(2):320-331.
33. Vanoirbeek J.A., Tarkowski M., Vanhooren H.M., De Vooght V., Nemery B., Hoet P.H. Validation of a mouse model of chemical-induced asthma using trimellitic anhydride, a respiratory sensitizer, and dinitrochlorobenzene, a dermal sensitizer. J. Allergy Clin. Immunol. 2006, 117:1090-1097.
34. Williams M.A., Georas S. Gene expression patterns and susceptibility to allergic responses. Exp. Rev. Clin. Immunol. 2006, 2:59-73.
35. World Health Organisation (WHO), 1998. Chromium Environmental Health Criteria No. 61. WHO, Geneva.
36. Xiang J., Rir-Sim-Ah J., Tesfaigzi Y. IL-9 and IL-13 induce mucus cell metaplasia that is reduced by IFN-γ in a bax-mediated pathway. Am. J. Respir. Cell Mol. Biol. 2008, 38:310-317.
37. Yamada A., Ohshima Y., Yasutomi M., Ogura K., Tokuriki S., Naiki H., Mayumi M. Antigen-primed splenic CD8+ T cells impede the development of oral antigen-induced allergic diarrhea. J. Allergy Clin. Immunol. 2009, 123:889-894.